PharmaNet/i3 introduces PharmaNet/i3 Strategic Resourcing

Thursday, June 28, 2012 11:46 AM

PharmaNet/i3, inVentiv Health’s clinical segment and provider of clinical development services, has launched PharmaNet/i3 Strategic Resourcing, a new unified provider of staffing and functional service provider (FSP) services.

Combining the capabilities of Kforce Clinical Research, i3 Pharma Resourcing, MedFocus, Smith Hanley Consulting Group and PharmaNet Resource Solutions, PharmaNet/i3 Strategic Resourcing connects the right resources across the clinical development spectrum to deliver tailored solutions to sponsors. Drawing upon more than 40 years of combined experience in FSP and staffing, PharmaNet/i3 Strategic Resourcing aims to help its clients address the growing pressures to enhance innovation, expedite pipelines and improve efficiencies, while lowering costs.

“With services that range from staffing individual positions to strategic FSP partnerships, PharmaNet/i3 Strategic Resourcing allows sponsors to outsource effectively and maintain the level of control they are most comfortable with,” said Gregg Dearhammer, president of PharmaNet/i3 Strategic Resourcing. “Clients choose what they need when they need it, and get the experience and expertise necessary for successful development programs.”

The FSP business unit of PharmaNet/i3 Strategic Resourcing will be under the leadership of Brian Thornton, senior vice president of strategic resourcing, who has over 20 years of experience in clinical research. The staffing business unit will be led by Kathy Hardy, president of staffing, who has more than 13 years of experience managing global staffing resources.

“At the end of the day, clients are looking for new models to address evolving market dynamics and explore ways to improve quality, increase efficiency and manage costs,” Dearhammer said.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs